IBDEI03X ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4836,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,4836,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,4837,0)
 ;;=692.81^^38^325^6
 ;;^UTILITY(U,$J,358.3,4837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4837,1,2,0)
 ;;=2^692.81
 ;;^UTILITY(U,$J,358.3,4837,1,5,0)
 ;;=5^Deodorant Dermatitis
 ;;^UTILITY(U,$J,358.3,4837,2)
 ;;=^271911
 ;;^UTILITY(U,$J,358.3,4838,0)
 ;;=693.0^^38^325^9
 ;;^UTILITY(U,$J,358.3,4838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4838,1,2,0)
 ;;=2^693.0
 ;;^UTILITY(U,$J,358.3,4838,1,5,0)
 ;;=5^Drug Dermatitis(Internal, Taken Appropriately)
 ;;^UTILITY(U,$J,358.3,4838,2)
 ;;=^33042
 ;;^UTILITY(U,$J,358.3,4839,0)
 ;;=692.3^^38^325^8
 ;;^UTILITY(U,$J,358.3,4839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4839,1,2,0)
 ;;=2^692.3
 ;;^UTILITY(U,$J,358.3,4839,1,5,0)
 ;;=5^Drug Dermatitis(External)
 ;;^UTILITY(U,$J,358.3,4839,2)
 ;;=^271905
 ;;^UTILITY(U,$J,358.3,4840,0)
 ;;=693.1^^38^325^12
 ;;^UTILITY(U,$J,358.3,4840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4840,1,2,0)
 ;;=2^693.1
 ;;^UTILITY(U,$J,358.3,4840,1,5,0)
 ;;=5^Food Dermatitis
 ;;^UTILITY(U,$J,358.3,4840,2)
 ;;=^33044
 ;;^UTILITY(U,$J,358.3,4841,0)
 ;;=692.0^^38^325^7
 ;;^UTILITY(U,$J,358.3,4841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4841,1,2,0)
 ;;=2^692.0
 ;;^UTILITY(U,$J,358.3,4841,1,5,0)
 ;;=5^Detergent Dermatitis
 ;;^UTILITY(U,$J,358.3,4841,2)
 ;;=^271902
 ;;^UTILITY(U,$J,358.3,4842,0)
 ;;=692.74^^38^325^22
 ;;^UTILITY(U,$J,358.3,4842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4842,1,2,0)
 ;;=2^692.74
 ;;^UTILITY(U,$J,358.3,4842,1,5,0)
 ;;=5^Sun Dermatitis, Chronic
 ;;^UTILITY(U,$J,358.3,4842,2)
 ;;=^293927
 ;;^UTILITY(U,$J,358.3,4843,0)
 ;;=694.9^^38^325^5
 ;;^UTILITY(U,$J,358.3,4843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4843,1,2,0)
 ;;=2^694.9
 ;;^UTILITY(U,$J,358.3,4843,1,5,0)
 ;;=5^Bullous dermatoses, NOS
 ;;^UTILITY(U,$J,358.3,4843,2)
 ;;=^187900
 ;;^UTILITY(U,$J,358.3,4844,0)
 ;;=692.73^^38^325^2
 ;;^UTILITY(U,$J,358.3,4844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4844,1,2,0)
 ;;=2^692.73
 ;;^UTILITY(U,$J,358.3,4844,1,5,0)
 ;;=5^Actinic Granuloma/Reticuloid
 ;;^UTILITY(U,$J,358.3,4844,2)
 ;;=Actinic Granuloma/Reticuloid^293926
 ;;^UTILITY(U,$J,358.3,4845,0)
 ;;=23^1^38^325^19^-Solar Dermatitis^1^1
 ;;^UTILITY(U,$J,358.3,4845,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,4846,0)
 ;;=692.72^^38^325^21
 ;;^UTILITY(U,$J,358.3,4846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4846,1,2,0)
 ;;=2^692.72
 ;;^UTILITY(U,$J,358.3,4846,1,5,0)
 ;;=5^Polymorphic Light Eruption
 ;;^UTILITY(U,$J,358.3,4846,2)
 ;;=Polymorphic Light Eruptio^93951
 ;;^UTILITY(U,$J,358.3,4847,0)
 ;;=110.0^^38^326^5
 ;;^UTILITY(U,$J,358.3,4847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4847,1,2,0)
 ;;=2^110.0
 ;;^UTILITY(U,$J,358.3,4847,1,5,0)
 ;;=5^Dermatophytosis Scalp
 ;;^UTILITY(U,$J,358.3,4847,2)
 ;;=^33176
 ;;^UTILITY(U,$J,358.3,4848,0)
 ;;=110.5^^38^326^1
 ;;^UTILITY(U,$J,358.3,4848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4848,1,2,0)
 ;;=2^110.5
 ;;^UTILITY(U,$J,358.3,4848,1,5,0)
 ;;=5^Dermatophytosis Body(Tinea Imbricata)
 ;;^UTILITY(U,$J,358.3,4848,2)
 ;;=^33179
 ;;^UTILITY(U,$J,358.3,4849,0)
 ;;=110.1^^38^326^6
 ;;^UTILITY(U,$J,358.3,4849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4849,1,2,0)
 ;;=2^110.1
 ;;^UTILITY(U,$J,358.3,4849,1,5,0)
 ;;=5^Onychomycosis
 ;;^UTILITY(U,$J,358.3,4849,2)
 ;;=Onychomycosis^33173
 ;;^UTILITY(U,$J,358.3,4850,0)
 ;;=110.4^^38^326^2
 ;;^UTILITY(U,$J,358.3,4850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4850,1,2,0)
 ;;=2^110.4
 ;;^UTILITY(U,$J,358.3,4850,1,5,0)
 ;;=5^Dermatophytosis Foot(Tinea Pedis)
 ;;^UTILITY(U,$J,358.3,4850,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,4851,0)
 ;;=110.3^^38^326^3
 ;;^UTILITY(U,$J,358.3,4851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4851,1,2,0)
 ;;=2^110.3
 ;;^UTILITY(U,$J,358.3,4851,1,5,0)
 ;;=5^Dermatophytosis Groin(Tinea Cruris)
 ;;^UTILITY(U,$J,358.3,4851,2)
 ;;=^33171
 ;;^UTILITY(U,$J,358.3,4852,0)
 ;;=110.2^^38^326^4
 ;;^UTILITY(U,$J,358.3,4852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4852,1,2,0)
 ;;=2^110.2
 ;;^UTILITY(U,$J,358.3,4852,1,5,0)
 ;;=5^Dermatophytosis Hand(Tinea Manuum)
 ;;^UTILITY(U,$J,358.3,4852,2)
 ;;=^266859
 ;;^UTILITY(U,$J,358.3,4853,0)
 ;;=111.0^^38^326^7
 ;;^UTILITY(U,$J,358.3,4853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4853,1,2,0)
 ;;=2^111.0
 ;;^UTILITY(U,$J,358.3,4853,1,5,0)
 ;;=5^Tinea Versicolor
 ;;^UTILITY(U,$J,358.3,4853,2)
 ;;=^119758
 ;;^UTILITY(U,$J,358.3,4854,0)
 ;;=706.8^^38^327^1
 ;;^UTILITY(U,$J,358.3,4854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4854,1,2,0)
 ;;=2^706.8
 ;;^UTILITY(U,$J,358.3,4854,1,5,0)
 ;;=5^Asteatotic Eczema
 ;;^UTILITY(U,$J,358.3,4854,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,4855,0)
 ;;=691.8^^38^327^5
 ;;^UTILITY(U,$J,358.3,4855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4855,1,2,0)
 ;;=2^691.8
 ;;^UTILITY(U,$J,358.3,4855,1,5,0)
 ;;=5^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,4855,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,4856,0)
 ;;=692.9^^38^327^8
 ;;^UTILITY(U,$J,358.3,4856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4856,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4856,1,5,0)
 ;;=5^Xerotic Eczema
 ;;^UTILITY(U,$J,358.3,4856,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4857,0)
 ;;=686.8^^38^327^6
 ;;^UTILITY(U,$J,358.3,4857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4857,1,2,0)
 ;;=2^686.8
 ;;^UTILITY(U,$J,358.3,4857,1,5,0)
 ;;=5^Pustular Eczema
 ;;^UTILITY(U,$J,358.3,4857,2)
 ;;=^88097
 ;;^UTILITY(U,$J,358.3,4858,0)
 ;;=690.18^^38^327^7
 ;;^UTILITY(U,$J,358.3,4858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4858,1,2,0)
 ;;=2^690.18
 ;;^UTILITY(U,$J,358.3,4858,1,5,0)
 ;;=5^Seborrheic Eczema
 ;;^UTILITY(U,$J,358.3,4858,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,4859,0)
 ;;=705.81^^38^327^3
 ;;^UTILITY(U,$J,358.3,4859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4859,1,2,0)
 ;;=2^705.81
 ;;^UTILITY(U,$J,358.3,4859,1,5,0)
 ;;=5^Dyshidrotic Eczema/Pompholyx
 ;;^UTILITY(U,$J,358.3,4859,2)
 ;;=Dyshidrotic Eczema/Pompholyx^96545
 ;;^UTILITY(U,$J,358.3,4860,0)
 ;;=692.9^^38^327^2
 ;;^UTILITY(U,$J,358.3,4860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4860,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4860,1,5,0)
 ;;=5^Atopic Eczema
 ;;^UTILITY(U,$J,358.3,4860,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4861,0)
 ;;=274.89^^38^327^4
 ;;^UTILITY(U,$J,358.3,4861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4861,1,2,0)
 ;;=2^274.89
 ;;^UTILITY(U,$J,358.3,4861,1,5,0)
 ;;=5^Gouty Eczema
 ;;^UTILITY(U,$J,358.3,4861,2)
 ;;=^267936
 ;;^UTILITY(U,$J,358.3,4862,0)
 ;;=782.3^^38^328^3
 ;;^UTILITY(U,$J,358.3,4862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4862,1,2,0)
 ;;=2^782.3
 ;;^UTILITY(U,$J,358.3,4862,1,5,0)
 ;;=5^Pitting Edema
 ;;^UTILITY(U,$J,358.3,4862,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,4863,0)
 ;;=459.2^^38^328^1
 ;;^UTILITY(U,$J,358.3,4863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4863,1,2,0)
 ;;=2^459.2
 ;;^UTILITY(U,$J,358.3,4863,1,5,0)
 ;;=5^Edema due To Venous Obstruction
 ;;^UTILITY(U,$J,358.3,4863,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,4864,0)
 ;;=457.1^^38^328^2
 ;;^UTILITY(U,$J,358.3,4864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4864,1,2,0)
 ;;=2^457.1
 ;;^UTILITY(U,$J,358.3,4864,1,5,0)
 ;;=5^Edema due to Lymphatic Obstruction
 ;;^UTILITY(U,$J,358.3,4864,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,4865,0)
 ;;=695.2^^38^329^2
 ;;^UTILITY(U,$J,358.3,4865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4865,1,2,0)
 ;;=2^695.2
 ;;^UTILITY(U,$J,358.3,4865,1,5,0)
 ;;=5^Erythema Nodosum
 ;;^UTILITY(U,$J,358.3,4865,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,4866,0)
 ;;=692.71^^38^329^3
 ;;^UTILITY(U,$J,358.3,4866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4866,1,2,0)
 ;;=2^692.71
 ;;^UTILITY(U,$J,358.3,4866,1,5,0)
 ;;=5^Erythema Solara
 ;;^UTILITY(U,$J,358.3,4866,2)
 ;;=^115798
 ;;^UTILITY(U,$J,358.3,4867,0)
 ;;=695.0^^38^329^4
 ;;^UTILITY(U,$J,358.3,4867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4867,1,2,0)
 ;;=2^695.0
 ;;^UTILITY(U,$J,358.3,4867,1,5,0)
 ;;=5^Erythema Toxic
 ;;^UTILITY(U,$J,358.3,4867,2)
 ;;=^265514
 ;;^UTILITY(U,$J,358.3,4868,0)
 ;;=695.10^^38^329^1
 ;;^UTILITY(U,$J,358.3,4868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4868,1,2,0)
 ;;=2^695.10
 ;;^UTILITY(U,$J,358.3,4868,1,5,0)
 ;;=5^Erythema Multiforme NOS
 ;;^UTILITY(U,$J,358.3,4868,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,4869,0)
 ;;=V15.89^^38^330^6
 ;;^UTILITY(U,$J,358.3,4869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4869,1,2,0)
 ;;=2^V15.89
 ;;^UTILITY(U,$J,358.3,4869,1,5,0)
 ;;=5^Persian Gulf Service
 ;;^UTILITY(U,$J,358.3,4869,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,4870,0)
 ;;=V15.84^^38^330^1
 ;;^UTILITY(U,$J,358.3,4870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4870,1,2,0)
 ;;=2^V15.84
 ;;^UTILITY(U,$J,358.3,4870,1,5,0)
 ;;=5^Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,4870,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,4871,0)
 ;;=V15.85^^38^330^2
 ;;^UTILITY(U,$J,358.3,4871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4871,1,2,0)
 ;;=2^V15.85
 ;;^UTILITY(U,$J,358.3,4871,1,5,0)
 ;;=5^Exposure To Body Fluids
 ;;^UTILITY(U,$J,358.3,4871,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,4872,0)
 ;;=V15.81^^38^330^5
 ;;^UTILITY(U,$J,358.3,4872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4872,1,2,0)
 ;;=2^V15.81
 ;;^UTILITY(U,$J,358.3,4872,1,5,0)
 ;;=5^Noncompliance With Treatment
 ;;^UTILITY(U,$J,358.3,4872,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,4873,0)
 ;;=V15.3^^38^330^3
 ;;^UTILITY(U,$J,358.3,4873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4873,1,2,0)
 ;;=2^V15.3
 ;;^UTILITY(U,$J,358.3,4873,1,5,0)
 ;;=5^Exposure To Radiation Therapy
 ;;^UTILITY(U,$J,358.3,4873,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,4874,0)
 ;;=V15.82^^38^330^4
 ;;^UTILITY(U,$J,358.3,4874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4874,1,2,0)
 ;;=2^V15.82
 ;;^UTILITY(U,$J,358.3,4874,1,5,0)
 ;;=5^Exposure To Tobacco
 ;;^UTILITY(U,$J,358.3,4874,2)
 ;;=^303405
